Prostate Cancer Screening Tampa FL
Prostate cancer screening is typically recommended for men who are 55 years of age and older, as well as younger men who have one or more known risk factors. Physicians often offer prostate-specific antigen (PSA) screenings in addition to traditional digital rectal exams. Whether used together or separately, these tests can help detect abnormal changes early in their development.
If you’re concerned about your prostate cancer risk, or if you already had a PSA elevation or abnormal DRE or both, please contact our oncologists to discuss next steps. Because every man’s needs are different, our team can help each patient determine the prostate cancer screening methods (and frequency) that are most appropriate for his situation.
Abnormal screening results do not always mean that cancer is present. At Moffitt, we are committed to providing each patient with the careful evaluation necessary for an accurate diagnosis. Should a patient’s screening results indicate an elevated PSA level or the presence of a palpable growth in the prostate gland, we can provide a comprehensive range of follow-up tests, including:
- X-rays
- Computed tomography (CT) scans
- Magnetic resonance imaging (MRI)
- Transrectal ultrasounds
- Cystoscopies and bladder scope testing
- Prostate biopsies
Because these tests are provided by a team of oncologists who specialize in prostate cancer (and the results are interpreted by similarly specialized radiologists and pathologists), we are able to promptly provide our patients with the information they need and deserve.
Referrals are never necessary for prostate cancer care at Moffitt. To request an appointment, call 1-888-663-3488Â or submit a new patient registration form online. We welcome patients from Tampa, FL, all other nearby areas.
Prostate Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer